Human Growth Hormone Induced Cholestatic Hepatitis in a Growth Hormone Deficient Patient with Short Stature
Current Drug Safety,
Mozhghan Zahmatkeshan, Zohre Karamizadeh, Bita Geramizadeh and Ahad EshraghianAffiliation:
Department of Internal Medicine, Namazi hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Case Description: We report a patient with growth hormone deficiency that developed cholestatic hepatitis during treatment with recombinant human growth hormone (HGH). The patient developed jaundice and pruritus during treatment with growth hormone. She did not use any other medications. Her jaundice and pruritus were disappeared and liver enzyme disturbances were normalized after HGH discontinuation.
Conclusion: Clinician should be aware of this potential adverse drug reaction and frequent checking of liver enzymes is recommended in patients treating with HGH.
Cholestatic hepatitis, human growth hormone, growth hormone deficiency.
Purchase Online Order Reprints Order Eprints Rights and Permissions